AFP’s financial results 2025: positive net profit for the seventh straight year despite a first decline in commercial sales since 2018

AFP’s board approved the 2025 accounts at its meeting of April 16, 2026.

AFP’s board approved the 2025 accounts at its meeting of April 16, 2026.
Anglais

South Korea aims to save seniors feeling lost in digital age

Home to some of the world’s leading technology companies, South Korea also has one of the starkest digital divides; an age gap in tech literacy that risks leaving some senior citizens stranded. In an effort to tackle this, the government organises training for older Koreans, with lessons on online shopping, using AI and interacting with everyday technology. “There were times when I felt so baffled,” says 70-year-old Yoon Bok-soon, one of those taking part in a session at a senior community centre south of Seoul. While rapidly embracing modern technology, South...

UN rights chief calls for 'urgent action' to rein in AI

United Nations human rights chief Volker Turk calls for “urgent action” to rein in “frontier” artificial intelligence, warning that the technology poses “unprecedented risks.” Turk’s comments come amid a flurry of concern over the risks posed by AI, with employees at the firm Anthropic expressing fears that the technology could escape human control, and CEOs Dario Amodei, Sam Altman and Elon Musk all showing support for a coordinated slowdown in...

Cyara Names Ben Corser to Lead Asia-Pacific Growth

Cyara, the AI trust company for customer experience, today announced the appointment ofBen Corseras General Manager and SVP, Go-to-Market for Asia-Pacific (APAC), reinforcing the company’s investment in Australia and its broader...
Anglais
09/10/2026 11:02
One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie

One Biosciences, a techbio company spun off from Institut Curie pioneering clinical-grade single-cell tumor profiling, and Institut Curie, the leading French center for the fight against cancer, today announced support from Bpifrance through the France 2030 i-Démo1 program for the CAST project (Cancer Single-cell Analysis for Therapy), securing €3,3 Million in funding. This milestone marks a major step forward in the development of single-cell tumor profiling technology for routine cancer care....